AERUMAB
USPTO Trademark Record · Serial No. 86652601
Trademark details
It was initially claimed by Aridis Pharmaceuticals Inc. on 20150605.
That brand applies to the following goods and services:Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use, Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for the treatment and prevention of pneumonia, cystic fibrosis, eye infection, bronchitis, bronchiectasis, urinary tract infections, COPD, bloodstream infection, skin infections, surgical related infections, endocarditis; Pharmaceutical products for the treatment of vir, Medical and scientific research in the field of infectious diseases; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the AERUMAB trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
